```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1193 Enrolled Bill (ENR)]

        H.R.1193

                    One Hundred Seventeenth Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

           Begun and held at the City of Washington on Monday,
          the third day of January, two thousand and twenty-two

                                 An Act

 
    To amend title IV of the Public Health Service Act to direct the 
Director of the National Institutes of Health, in consultation with the 
Director of the National Heart, Lung, and Blood Institute, to establish 
a program under which the Director of the National Institutes of Health 
  shall support or conduct research on valvular heart disease, and for 
                             other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
    This Act may be cited as the ``Cardiovascular Advances in Research 
and Opportunities Legacy Act''.
SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES.
    (a) In General.--The Secretary of Health and Human Services 
(referred to in this section as the ``Secretary'') shall, as 
appropriate, continue activities related to research, education, and 
awareness of valvular heart diseases.
    (b) NIH Research Related to Valvular Heart Diseases.--
        (1) In general.--The Director of the National Institutes of 
    Health, in consultation with the Director of the National Heart, 
    Lung, and Blood Institute, may support or conduct research 
    regarding valvular heart diseases.
        (2) Support further research.--In order to improve information 
    on, and understanding of, causation and risk factors for valvular 
    heart diseases, research conducted or supported under this 
    subsection for such diseases may include the following:
            (A) Use of advanced technological imaging and other 
        relevant methods to generate data related to valvular heart 
        diseases.
            (B) Assessing potential risk factors for sudden cardiac 
        arrest or sudden cardiac death from valvular heart diseases.
            (C) Other activities, as appropriate, in order to improve 
        the availability of information on, and advance research 
        related to, valvular heart diseases.
        (3) Mitral valve prolapse workshop.--Not later than 2 years 
    after the date of enactment of this Act, the Director of the 
    National Heart, Lung, and Blood Institute shall, as appropriate, 
    convene a workshop composed of subject matter experts and 
    stakeholders to identify research needs and opportunities to 
    develop recommendations for the identification and treatment of 
    individuals with mitral valve prolapse, including such individuals 
    who may be at risk for sudden cardiac arrest or sudden cardiac 
    death.
    (c) Prevention Activities to Improve Awareness of Sudden Cardiac 
Death as a Result of Valvular Heart Diseases.--
        (1) In general.--The Secretary may carry out activities to 
    increase education and awareness of valvular heart diseases in 
    order to reduce the incidence of sudden cardiac death caused by 
    such diseases. The Secretary may--
            (A) award grants or contracts to public or nonprofit 
        private entities to carry out activities under this subsection; 
        and
            (B) directly, or through grants or contracts, provide 
        technical assistance with respect to such activities.
        (2) Certain activities.--Upon availability of applicable data, 
    projects carried out under paragraph (1) may include--
            (A) continuing activities at the Centers for Disease 
        Control and Prevention related to valvular heart diseases;
            (B) improving the awareness of the public concerning any 
        risk factors for, the symptoms of, and the public health impact 
        of, valvular heart diseases; and
            (C) enhancing public health data collection and improving 
        the quality of such data, as appropriate, regarding cardiac 
        arrests, including cardiac arrests that occur outside of the 
        hospital.
        (3) Grant prioritization.--The Secretary may, in awarding 
    grants or entering into contracts pursuant to paragraph (1), give 
    priority to entities seeking to carry out projects for populations 
    most impacted by valvular heart diseases.
        (4) Coordination of activities.--The Secretary shall, as 
    appropriate, ensure that activities under this section are 
    coordinated with other agencies and offices of the Department of 
    Health and Human Services that carry out activities regarding 
    valvular heart diseases.
        (5) Best practices.--The Secretary shall, as applicable and 
    appropriate, identify and disseminate best practices for relevant 
    health care providers related to valvular heart diseases.
    (d) Authorization of Appropriations.--For purposes of carrying out 
this section, there are authorized to be appropriated $28,000,000 for 
each of fiscal years 2023 through 2027.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```